Andreas Johne
5PUBLICATIONS
32CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|May 01, 2025
Liquid and Tissue Biopsies for Identifying MET Exon 14 Skipping NSCLC: Analyses from the Phase II VISION Study of Tepotinib.Christian Rolfo, Aurora O'Brate, Christoph Menzel
|Sep 02, 2024
Explainable machine learning prediction of edema adverse events in patients treated with tepotinib.Federico Amato, Rainer Strotmann, Roberto Castello
|Feb 14, 2024
Activity of Tepotinib in Hepatocellular Carcinoma With High-Level MET Amplification: Preclinical and Clinical Evidence.Shukui Qin, Hongming Pan, Jean Frédéric Blanc
|Mar 31, 2023
The Preclinical Pharmacology of Tepotinib-A Highly Selective MET Inhibitor with Activity in Tumors Harboring MET Alterations.Joachim Albers, Manja Friese-Hamim, Anderson Clark
|Mar 27, 2023
Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis.Chong Kin Liam, Azura Rozila Ahmad, Te-Chun Hsia
Pageof 1
Frequent Collaborators
2 joint publications
Christopher Stroh
2 joint publications
Joachim Albers
2 joint publications
Rolf Bruns
1 joint publications
Paul K Paik
1 joint publications
Azura Rozila Ahmad
1 joint publications
Te-Chun Hsia
1 joint publications
Jianying Zhou
1 joint publications
Dong-Wan Kim
1 joint publications
Ross Andrew Soo
1 joint publications
Shun Lu
